Position in CRBU
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$913,375
+$322,894 QoQ
Shares Held
480,724
+29.4% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#22
of 137 holders
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GSA CAPITAL PARTNERS LLP holds $99,952,720 across 160 Biotechnology names. CRBU ranks #45 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,831 | $2,959,983 | |
| 2 | ARDX |
Ardelyx, Inc.
|
473,061 | $2,833,635 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
178,301 | $2,285,818 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
495,792 | $2,126,947 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
669,568 | $2,055,573 | |
| 6 | WVE |
Wave Life Sciences Ltd.
|
282,719 | $2,049,712 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
90,960 | $1,979,289 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
557,085 | $1,955,368 |
All Filings in CRBU
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $913,375 | 480,724 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $590,481 | 371,372 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $209,658 | 166,396 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $16,073 | 17,605 | Shares | Sole | 2025-05-08 | |
| 2023-09-30 | $51,308 | 10,734 | Shares | Sole | 2023-11-15 | |
| 2022-06-30 | $80,999 | 14,917 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $229,692 | 25,021 | Shares | Sole | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||